Montelukast Prescribing at CENTRAL PARK SURGERY
Cromoglycate, leukotriene and phosphodesterase type-4 inhib | Respiratory System
Items (12m)
939
Total Quantity
19.3K
NHS Cost
£922
vs National Avg
+37.1%
CENTRAL PARK SURGERY prescribed 939 items of Montelukast over the last 12 months at a cost of £922 to the NHS. This is 37.1% above the national average prescribing rate. Montelukast is classified under Cromoglycate, leukotriene and phosphodesterase type-4 inhib in the BNF.
Monthly Prescribing Trend
Jul 2026
100
Jul 2026
72
Jul 2026
88
Jul 2026
72
Jul 2026
73
Jul 2026
82
Jul 2026
81
Jul 2026
82
Jul 2026
86
Jul 2026
69
Jul 2026
66
Jul 2026
68
Prescribing Details
| Total Items | 939 |
|---|---|
| Total Quantity | 19,320 |
| Total NHS Cost | £922 |
| Presentations | 4 different forms |
| vs National Average | +37.1% |
Montelukast Prescribing Comparison
| This practice | 939 items |
|---|---|
| National average per practice | 685 items |
| Difference | +37.1% vs national average |
Explore More
Data sourced from NHSBSA English Prescribing Dataset, CQC, and GP Patient Survey. Prescribing data does not indicate quality of care. Higher prescribing rates may reflect patient demographics. Always consult your GP for medical advice.